UBS Group’s Virax Biolabs VRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,425
| Closed | -$25.6K | – | 9377 |
|
|
2025
Q1 | $25.6K | Sell |
22,425
-15,490
| -41% | -$17.7K | ﹤0.01% | 6753 |
|
|
2024
Q4 | $85.3K | Buy |
37,915
+17,385
| +85% | +$39.1K | ﹤0.01% | 5757 |
|
|
2024
Q3 | $39.8K | Buy |
20,530
+14,929
| +267% | +$29K | ﹤0.01% | 5763 |
|
|
2024
Q2 | $6.5K | Buy |
5,601
+3,026
| +118% | +$3.51K | ﹤0.01% | 6756 |
|
|
2024
Q1 | $1.85K | Buy |
2,575
+1,910
| +287% | +$1.37K | ﹤0.01% | 6861 |
|
|
2023
Q4 | $971 | Buy |
665
+650
| +4,333% | +$949 | ﹤0.01% | 7238 |
|
|
2023
Q3 | $48 | Buy |
+15
| New | +$48 | ﹤0.01% | 7862 |
|
|
2023
Q2 | – | Sell |
-307
| Closed | -$2.13K | – | 8456 |
|
|
2023
Q1 | $2.13K | Sell |
307
-312
| -50% | -$2.17K | ﹤0.01% | 7470 |
|
|
2022
Q4 | $4.52K | Sell |
619
-601
| -49% | -$4.38K | ﹤0.01% | 8127 |
|
|
2022
Q3 | $38K | Buy |
+1,220
| New | +$38K | ﹤0.01% | 5540 |
|